A prospective randomized study of the usfulness of the artery first approach in pancreatic cancer with pancreaticoduodenectomy
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0003829
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 268
Inclusion Criteria
1. The patients who need to undergo pancreatoduodnectomy for pancreatic head cancer
2. No systemic metastasis
3. more than 20 years old
4. Patients who can read and understand the informed consent and can express their intent to agree
Exclusion Criteria
1. Systemic metastasis
2. Neoadjuvant chemothearpy for borderline resectable pancreatic cancer or locally advanced pancreatic cancer
3.. patients who need reconstruct artery
4. Ischemic heart disease
5. Severe liver failure, liver cirrhosis
6. Respiratory distress with oxygen therapy
7. Chronic kidney disease with hemodialysis
8. severe psychological or neurological disease
9. Drug abuse, alcoholism
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The 2 year recurrence free survival rate;recurrence pattern
- Secondary Outcome Measures
Name Time Method blood loss, interaopeative transfusion rate;overall complication;R0 resection rete;lenght of hospital stay;recurrence pattern;3 months death rate;re-operation, re-admission